Back to search

Antikor Biopharma Limited

04170519

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

MONTAGUE HOUSE, THRAPSTON, NN14 4LN
Incorporated 01/03/2001

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72190
Other research and experimental development on natural sciences and engineering

Officers

Dr Mahendra Persaud Deonarain Bsc Phd

director · Since 16/09/2005

SEN LECTURER

BRITISH · ENGLAND · Age 59

Also on 2 other boards

Dr Mahendra Persaud Deonarain

director · Since 16/09/2005

SEN LECTURER

BRITISH · ENGLAND · Age 59

Mr Hian Leng Malcolm Ngiam

director · Since 21/01/2019

DEPUTY MANAGING DIRECTOR

SINGAPOREAN · SINGAPORE · Age 41

Mr Joseph Bernard O'Sullivan

director · Since 13/05/2023

CONSULTANT

BRITISH · SWITZERLAND · Age 56

Dr Qi Xue

director · Since 30/06/2025

CHIEF SCIENTIFIC OFFICER

AMERICAN · UNITED STATES · Age 65

Persons with Significant Control

Mr Mia Je Patrick Ngiam

Significant control

Singaporean · Singapore · Age 71

Antikor Biopharma Limited, Stevenage Bioscience Catalyst, Stevenage, SG1 2FX

Notified 15/12/2025

Mr Hian Leng Malcolm Ngiam

Significant control

Singaporean · Singapore · Age 41

Antikor Biopharma Limited, Stevenage Bioscience Catalyst, Stevenage, SG1 2FX

Notified 15/12/2025

Former PSCs

Lj Capital Limited

Ceased 24/07/2019

Mr George Albert Brown

Ceased 03/10/2025

CompanyRankvs 2371+ SIC 72190 peers
60

Financial strength99th percentile among SIC peers · 25/25
Employees20th percentile among SIC peers · 3/15
LiquidityCurrent ratio 0.24× · 2/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/07/2025

Net Worth

£9.2M

Balance sheet strength

Cash

£109k

Cash in the bank

Net Current Assets

-£1.3M

Working capital

Current Assets

£410k

Current Liabilities

£1.7M

Fixed Assets

£21k

Debtors

£301k

Profit After Tax

£493k

0avg. employees-12

Balance Sheet

Intangible assets£89k
Assets less current liabilities£12.0M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20250.24+£9.0M
2024+£0

Derived from filed accounts. Not audited figures.